ProstaLund Past Earnings Performance

Past criteria checks 0/6

ProstaLund's earnings have been declining at an average annual rate of -16.9%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 10% per year.

Key information

-16.9%

Earnings growth rate

13.5%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate10.0%
Return on equity-34.4%
Net Margin-122.0%
Next Earnings Update20 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How ProstaLund makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:7PL0 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2416-20225
30 Jun 2418-22255
31 Mar 2420-19245
31 Dec 2322-17235
30 Sep 2321-17265
30 Jun 2320-13225
31 Mar 2318-12214
31 Dec 2217-11204
30 Sep 2217-10194
30 Jun 2217-10203
31 Mar 2216-9193
31 Dec 2117-8193
30 Sep 2116-9193
30 Jun 2115-9184
31 Mar 2113-10164
31 Dec 2012-10164
30 Sep 2012-9153
30 Jun 2013-9163
31 Mar 2014-9163
31 Dec 1913-11173
30 Sep 1913-12183
30 Jun 1914-12182
31 Mar 1914-12192
31 Dec 1814-13202
30 Sep 1813-15222
30 Jun 1814-14222
31 Mar 1813-17242
31 Dec 1714-17251
30 Sep 1714-16231
30 Jun 1713-16231
31 Mar 1715-12201
31 Dec 1615-12201
30 Sep 1615-10181
30 Jun 1615-11171
31 Mar 1614-11171
31 Dec 1514-9161
30 Sep 1512-9161
30 Jun 1512-9171
31 Mar 1511-7161
31 Dec 1410-8151
30 Sep 149-8141
30 Jun 149-7121
31 Mar 148-6111
31 Dec 139-5101

Quality Earnings: 7PL0 is currently unprofitable.

Growing Profit Margin: 7PL0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7PL0 is unprofitable, and losses have increased over the past 5 years at a rate of 16.9% per year.

Accelerating Growth: Unable to compare 7PL0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7PL0 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 7PL0 has a negative Return on Equity (-34.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 13:48
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ProstaLund AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Markus AugustssonCarlsquare AB